Mackenzie Financial’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-35,094
Closed -$248K 1734
2024
Q4
$248K Buy
+35,094
New +$279K ﹤0.01% 1460
2024
Q3
Sell
-10,922
Closed -$69.8K 1627
2024
Q2
$69.8K Buy
+10,922
New +$70.1K ﹤0.01% 1464
2024
Q1
Sell
-18,626
Closed -$172K 1562
2023
Q4
$172K Buy
+18,626
New +$152K ﹤0.01% 1356

Other funds holding HCAT

Mackenzie Financial's HCAT Position: Q1 2025 in Review

Mackenzie Financial sold out of Health Catalyst (HCAT) in Q1 2025, closing a stake of 35,094 shares — an estimated $248K sold.

Mackenzie Financial first reported a position in HCAT in Q4 2023 and held it in 3 quarters. The position peaked at $248K in Q4 2024. 165 funds tracked by Wall St. Rank hold HCAT as of Q1 2025.

  • Mackenzie Financial reported no remaining Health Catalyst position as of Q1 2025 after selling out during the quarter.
  • Mackenzie Financial sold 35,094 Health Catalyst shares in Q1 2025, an estimated $248K.
  • Mackenzie Financial first reported a position in Health Catalyst in Q4 2023 and held it in 3 quarters.
  • Mackenzie Financial's Health Catalyst position peaked at $248K in Q4 2024.
  • 165 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2025.

Based on Mackenzie Financial's 13F filing for Q1 2025, filed 7 May 2025.